Literature DB >> 11892514

Therapy and disease concepts: the history (and future?) of antimony in cancer.

Jacalyn Duffin, Barbara G Campling.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11892514     DOI: 10.1093/jhmas/57.1.61

Source DB:  PubMed          Journal:  J Hist Med Allied Sci        ISSN: 0022-5045            Impact factor:   2.088


× No keyword cloud information.
  3 in total

1.  12 Arylstibonic acids that inhibit the DNA binding of five B-ZIP dimers.

Authors:  Vikas Rishi; Won-Jun Oh; Sarah L Heyerdahl; Jianfei Zhao; Dominic Scudiero; Robert H Shoemaker; Charles Vinson
Journal:  J Struct Biol       Date:  2010-02-20       Impact factor: 2.867

Review 2.  Availability, Toxicology and Medical Significance of Antimony.

Authors:  Argyrios Periferakis; Ana Caruntu; Aristodemos-Theodoros Periferakis; Andreea-Elena Scheau; Ioana Anca Badarau; Constantin Caruntu; Cristian Scheau
Journal:  Int J Environ Res Public Health       Date:  2022-04-12       Impact factor: 4.614

3.  Antispermatogenic activity of the benzothiazoline ligand and corresponding organoantimony(V) derivative in male albino rats.

Authors:  Pankaj K Sharma; H Rehwani; A K Rai; R S Gupta; Y P Singh
Journal:  Bioinorg Chem Appl       Date:  2006-04-18       Impact factor: 7.778

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.